Versor Investments’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Versor Investments’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,006	Closed	-$2.63M	–	268
2020 Q4	$2.63M	Buy	+20,006	New	+$1.77M	0.23%	24

Versor Investments's EIDX Position: Q1 2021 in Review

Versor Investments sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 20,006 shares — an estimated $2.63M sold.

Versor Investments first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $2.63M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Versor Investments reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Versor Investments sold 20,006 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $2.63M.
Versor Investments first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Versor Investments's Eidos Therapeutics, Inc. Common Stock position peaked at $2.63M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Versor Investments's 13F filing for Q1 2021, filed 10 May 2021.